Sign in
NNVC Stock Price, Chart, Stats & News
NanoViricides, Inc.
Save
NanoViricides, Inc. (NNVC) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
NNVC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -0.00% |
ROE | -0.00% |
D/E | – |
Interest coverage ratio | – |
NNVC valuation
P/E | – |
P/S | – |
P/B | 0.00x |
P/CF | -0.00x |
P/FCF | -0.00x |
P/OCF | -0.00x |
PEG | -0.37x |
EV multiple | -667808.62x |
About
NanoViricides, Inc. operates as a nano-biopharmaceutical entity, specializing in the research, development, and market introduction of pharmaceutical solutions to combat viral infections. The company's robust product pipeline includes a Human Coronavirus Program, specifically engineered to tackle both COVID-19 and various seasonal coronaviruses. For herpes-related conditions, it offers HerpeCide in multiple forms: dermal topical and eye drops to treat ailments such as shingles, postherpetic neuralgia (PHN), chickenpox, recurrent herpes labialis, genital herpes, and ocular herpes keratitis.
Similar securities
Based on sector and market capitalization
Report issue